HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States... Show more
HCA Healthcare operates one of the largest networks of hospitals and ambulatory surgery centers in the United States. This scale provides competitive advantages through centralized purchasing, standardized clinical protocols, and data-driven operational improvements that smaller competitors may struggle to replicate. The company continues to focus on expanding its footprint in high-growth markets while optimizing its existing portfolio for efficiency. Structural positioning benefits from vertical integration opportunities in outpatient services and physician practices, which support revenue diversification beyond traditional inpatient care. Medium-term outlook hinges on the ability to maintain market share amid ongoing industry consolidation and evolving care delivery models.
Scheduled quarterly earnings reports will provide updated visibility into same-facility revenue trends, admission volumes, and expense management. Management commentary on capital allocation, including potential share repurchases or facility expansions, often influences forward expectations. Regulatory developments related to Medicare reimbursement rates and potential policy shifts under evolving healthcare legislation could materially affect operating margins. Analyst rating changes and price target revisions from major firms continue to serve as sentiment indicators; recent consensus data shows a Moderate Buy stance with average targets reflecting potential upside from prevailing levels. Strategic partnerships or technology investments in areas such as telehealth and electronic health records may also emerge as incremental catalysts.
The broader healthcare sector faces ongoing pressure from rising labor costs and supply chain expenses, which directly impact hospital operators like HCA Healthcare. Interest rate levels influence the cost of financing new construction and equipment upgrades, while inflation trends affect both operating expenses and negotiated reimbursement rates. Consumer demand cycles tied to employment levels and insurance coverage expansions or contractions remain relevant. Geopolitical or policy developments that alter federal healthcare spending priorities could shift payer mix dynamics. Technology adoption, including artificial intelligence applications in diagnostics and administrative functions, offers potential efficiency gains but requires significant investment. The regulatory climate surrounding value-based care models and site-neutral payment policies will continue to shape strategic priorities.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality. Explore the Trend Prediction Engine for additional insights.
Looking toward 2026 and beyond, HCA Healthcare’s trajectory will be influenced by sustained demand growth from demographic trends and potential opportunities in outpatient and ambulatory care expansion. Cost structure evolution through operational efficiencies and supply chain optimization could support margin sustainability amid reimbursement pressures. Technology transitions, including digital health platforms and data analytics, represent areas for competitive differentiation. Capital allocation priorities may emphasize disciplined growth alongside shareholder returns. Consensus analyst expectations reflect a generally constructive long-term view, with attention to how regulatory developments and competitive dynamics unfold. Market participants will monitor the company’s ability to navigate payer negotiations and maintain volume growth in a consolidating industry landscape.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of health care services
Industry HospitalNursingManagement
A.I.dvisor indicates that over the last year, HCA has been closely correlated with UHS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if HCA jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To HCA | 1D Price Change % |
|---|---|---|
| HCA | 100% | +1.00% |
| HCA (2 stocks) | 97% Closely correlated | +0.68% |
| Hospital/Nursing Management (49 stocks) | 16% Poorly correlated | +0.81% |
The 10-day moving average for HCA crossed bullishly above the 50-day moving average on July 31, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 28, 2026. You may want to consider a long position or call options on HCA as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HCA just turned positive on July 28, 2026. Looking at past instances where HCA's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
HCA moved above its 50-day moving average on July 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HCA advanced for three days, in of 350 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 321 cases where HCA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for HCA moved out of overbought territory on July 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 49 similar instances where the indicator moved out of overbought territory. In of the 49 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where HCA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HCA broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (229.515). P/E Ratio (13.635) is within average values for comparable stocks, (124.043). Projected Growth (PEG Ratio) (1.316) is also within normal values, averaging (1.756). Dividend Yield (0.007) settles around the average of (0.014) among similar stocks. P/S Ratio (1.194) is also within normal values, averaging (2.640).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HCA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.